Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Respiratory Journal

• Publication date

  2016-10-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/13993003.00823-2016PMID 27799387PMCID PMC5437721
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Desipramine Increases Genioglossus Activity and Reduces Upper Airway Collapsibility during Non-REM Sleep in Healthy Subjects.

  2016cited by this paper
• Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea.

  2015cited by this paper
• Night-to-night Variability in Obstructive Sleep Apnea Severity: Relationship to Overnight Rostral Fluid Shift

  2015cited by this paper
• Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea.

  2014cited by this paper
• Upper-airway stimulation for obstructive sleep apnea.

  2014cited by this paper
• Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold.

  2014cited by this paper
• Hypoglossal-nerve stimulation for obstructive sleep apnea.

  2014cited by this paper
• TRAZODONE THE IN Trazodone Increases the Respiratory Arousal Threshold in Patients with Obstructive Sleep Apnea and a Low Arousal Threshold

  2014cited by this paper
• Quantifying the ventilatory control contribution to sleep apnoea using polysomnography

  2014cited by this paper
• A simplified method for determining phenotypic traits in patients with obstructive sleep apnea.

  2013cited by this paper
• Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

  2013cited by this paper
• Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events

  2012cited by this paper
• Obstructive sleep apnea.

  2012cited by this paper
• Response of genioglossus muscle to increasing chemical drive in sleeping obstructive apnea patients.

  2011cited by this paper
• A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions.

  2011cited by this paper
• The minimum period of polysomnography required to confirm a diagnosis of severe obstructive sleep apnoea

  2011cited by this paper
• Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.

  2010cited by this paper
• The effect of increased genioglossus activity and end-expiratory lung volume on pharyngeal collapse.

  2010cited by this paper
• Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure: The Sleep Heart Health Study

  2010cited by this paper
• Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.

  2010cited by this paper
• Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.

  2009cited by this paper
• Sleep-Disordered Breathing and Mortality: A Prospective Cohort Study

  2009cited by this paper
• The epidemiology of adult obstructive sleep apnea.

  2008cited by this paper
• Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea.

  2008cited by this paper
• Norepinephrine Transporter Regulation Mediates the Long-Term Behavioral Effects of the Antidepressant Desipramine

  2008cited by this paper
• Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

  2007cited by this paper
• Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states.

  2006cited by this paper
• Upper airway response to electrical stimulation of the genioglossus in obstructive sleep apnea.

  2003cited by this paper
• The influence of lung volume on pharyngeal mechanics, collapsibility, and genioglossus muscle activation during sleep.

  2003cited by this paper
• Pharyngeal pressure and flow effects on genioglossus activation in normal subjects.

  2002cited by this paper
• Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research

  2000cited by this paper
• Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

  1999cited by this paper
• The hypotonic upper airway in obstructive sleep apnea: role of structures and neuromuscular activity.

  1998cited by this paper
• Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing.

  1996cited by this paper
• Factors associated with nightly variability in sleep-disordered breathing in the elderly.

  1991cited by this paper
• Response of obstructive sleep apnea to fluoxetine and protriptyline.

  1991cited by this paper
• Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome.

  1988cited by this paper
• Obstructive sleep apnea.

  1987cited by this paper
• The effects of protriptyline in sleep-disordered breathing.

  1983cited by this paper
• Protriptyline in obstructive sleep apnea: a double-blind trial.

  1982cited by this paper
• Protriptyline in the treatment of sleep apnoea.

  1982cited by this paper
• Pharmacokinetic linearity of desipramine hydrochloride.

  1981cited by this paper

• Developments in Pharmacotherapy for Obstructive Sleep Apnoea: Unlocking the Potential for Targeted Treatment

  2025cites this paper
• Research Priorities for Translating Endophenotyping of Adult Obstructive Sleep Apnea to the Clinic: An Official American Thoracic Society Research Statement

  2025cites this paper
• Atomoxetine plus oxybutynin for symptomatic snoring and airflow limitation in individuals without moderate-to-severe obstructive sleep apnea

  2025cites this paper
• Wird es doch eine medikamentöse Therapie der OSA geben?

  2025cites this paper
• OSA pathophysiology: a contemporary update.

  2025cites this paper
• Myofunctional therapy for obstructive sleep apnoea.

  2025cites this paper
• Endotypic traits of supine position and supine-predominant obstructive sleep apnoea in Asian patients

  2024cites this paper
• A novel TASK channel antagonist nasal spray reduces sleep apnea severity in physiological responders: A randomized, blinded, trial.

  2024cites this paper
• Chinese consensus report on the assessment and management of obstructive sleep apnea in patients with cardiovascular disease: 2024 edition.

  2024cites this paper
• Treatable Traits-Based Pharmacologic Treatment of Sleep Apnea.

  2024cites this paper
• Combination Drug Therapy with Acetazolamide, Eszopiclone +/- Venlafaxine for Obstructive Sleep Apnea (RESCUE-Combo): A Randomized, Double-blind, Placebo-controlled Trial.

  2024cites this paper
• Tackling obstructive sleep apnea with pharmacotherapeutics: expert guidance

  2024influential citation
• A Comprehensive Review of Solriamfetol to Treat Excessive Daytime Sleepiness.

  2024cites this paper
• Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway

  2023cites this paper
• The effects of atomoxetine and trazodone combination on obstructive sleep apnea and sleep microstructure: A double-blind randomized clinical trial study.

  2023cites this paper
• Summary of drug therapy to treat cognitive impairment-induced obstructive sleep apnea

  2023cites this paper
• Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits

  2023cites this paper
• Translation of obstructive sleep apnea pathophysiology and phenotypes to personalized treatment: a narrative review

  2023cites this paper
• Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies

  2023cites this paper
• Continuous positive airway pressure and adherence in patients with different endotypes of obstructive sleep apnea

  2023cites this paper
• Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

  2023cites this paper
• Night-to-Night Reliability and Agreement of Physiological Endotypes: Two Steps Forward, One Step Back.

  2023cites this paper
• New Metrics from Polysomnography: Precision Medicine for OSA Interventions

  2023cites this paper
• Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double blind, crossover trial.

  2023cites this paper
• The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial

  2023cites this paper
• Night-to-Night Variability of Polysomnography-Derived Physiologic Endotypic Traits in Patients With Moderate to Severe OSA

  2023cites this paper
• Clinical Polysomnographic Methods for Estimating Pharyngeal Collapsibility in Obstructive Sleep Apnea.

  2022cites this paper
• One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.

  2022cites this paper
• Personalized Medicine and Obstructive Sleep Apnea

  2022cites this paper
• Topical K+ channel blockage improves pharyngeal collapsibility: A translational, placebo-controlled trial.

  2022cites this paper
• Obstructive Sleep Apnoea: Focus on Pathophysiology.

  2022cites this paper
• Differential pharmacological and sex-specific effects of antimuscarinic agents at the hypoglossal motor nucleus in vivo in rats

  2022cites this paper
• Obstructive sleep apnea.

  2022cites this paper
• A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity

  2022cites this paper
• The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial

  2022cites this paper
• Breathing during sleep.

  2022cites this paper
• Understanding Stability of OSA Endotypes: a step forward.

  2022cites this paper
• Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility

  2022cites this paper
• The Combination of Betahistine and Oxybutynin Increases Respiratory Control Sensitivity (Loop Gain) in People with Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Trial

  2022cites this paper
• The role of monoaminergic neurons in modulating respiration during sleep and the connection with SUDEP.

  2022cites this paper
• Overview of the Role of Pharmacological Management of Obstructive Sleep Apnea

  2022cites this paper
• An Update on Obstructive Sleep Apnea for Atherosclerosis: Mechanism, Diagnosis, and Treatment

  2021cites this paper
• Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial

  2021cites this paper
• Gene delivery to the hypoglossal motor system: preclinical studies and translational potential

  2021cites this paper
• Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.

  2021cites this paper
• New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review.

  2021cites this paper
• Obstructive Sleep Apnea Phenotyping to Understand Pathophysiology and Improve Treatment and Outcomes

  2021cites this paper
• Muscular Assessment in Patients With Severe Obstructive Sleep Apnea Syndrome: Protocol for a Case-Control Study

  2021cites this paper
• Long-term atomoxetine-oxybutynin combination use may be beneficial for the prevention of obstructive sleep apnea

  2021cites this paper
• The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double‐blind, placebo‐controlled, randomised crossover trial

  2021cites this paper
• Non-continuous positive airway pressure treatment options in obstructive sleep apnoea: A pathophysiological perspective.

  2021cites this paper
• Quantification of Airway Conductance from Non-invasive Ventilatory Drive in Patients with Sleep Apnea.

  2021cites this paper
• Novel avenues to approach non-CPAP therapy and implement comprehensive obstructive sleep apnoea care

  2021cites this paper
• A Novel Model to Estimate Key Obstructive Sleep Apnea Endotypes from Standard Polysomnography and Clinical Data and Their Contribution to Obstructive Sleep Apnea Severity

  2021cites this paper
• Apneas of Heart Failure and Phenotype-Guided Treatments: Part One: OSA.

  2020cites this paper
• An assessment of a simple clinical technique to estimate pharyngeal collapsibility in people with OSA.

  2020cites this paper
• Effect of Venlafaxine on Apnea-Hypopnea Index in Patients With Sleep Apnea

  2020influential citation
• A Novel Model to Estimate Key OSA Endotypes from Standard Polysomnography and Clinical Data and Their Contribution to OSA Severity.

  2020cites this paper
• Journey towards a personalised medicine approach for OSA: Can a similar approach to adult OSA be applied to paediatric OSA?

  2020cites this paper
• Effects of the Combination of Atomoxetine and Oxybutynin on Obstructive Sleep Apnea Endotypic Traits.

  2020cites this paper
• The Effect of Venlafaxine on Apnea Hypopnea Index in Patients with Sleep Apnea - a Randomized, Double-Blind Crossover Study.

  2020cites this paper
• Efficacy of Antidepressants in the Treatment of Obstructive Sleep Apnea Compared to Placebo. A Systematic Review with Meta-Analyses.

  2019cites this paper
• Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature

  2019influential citation
• Efficacy of pharmacotherapy for OSA in adults: A systematic review and network meta-analysis.

  2019cites this paper
• Sleep Apnea Phenotyping: Implications for Dental Sleep Medicine

  2019cites this paper
• Prise en charge thérapeutique du syndrome d’apnées obstructives du sommeil : vers une médecine personnalisée

  2019cites this paper
• Obstructive Sleep Apnea: Emerging Treatments Targeting the Genioglossus Muscle

  2019cites this paper
• Phenotypic approach to pharmacotherapy in the management of obstructive sleep apnoea.

  2019cites this paper
• The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.

  2019cites this paper
• The pharmacotherapeutic management of obstructive sleep apnea

  2019cites this paper
• More than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea.

  2019cites this paper
• Upper airway collapsibility measured using a simple wakefulness test closely relates to the pharyngeal critical closing pressure (Pcrit) during sleep in obstructive sleep apnea.

  2019cites this paper
• Drug Discovery and Emerging Treatments for Sleep Disorders

  2019cites this paper
• Drug therapy for obstructive sleep apnea: From pump to pill?

  2019cites this paper
• Reply to Patel and Althouse: Robust Methods Are Needed to Evaluate the Pharmacologic Treatment of Obstructive Sleep Apnea

  2019cites this paper
• Pharmacotherapy of Obstructive Sleep Apnea: Is Salvation Just Around a Corner?

  2019influential citation
• Phenotypic approaches to obstructive sleep apnoea - New pathways for targeted therapy.

  2018cites this paper
• Obstructive sleep apnea: current perspectives

  2018cites this paper
• Year in review 2017: Interstitial lung disease, pulmonary vascular disease and sleep

  2018cites this paper
• On the Generation of Rapid Eye Movement Sleep and the Reversal of Sleep-Related Hypotonia in Muscles of the Upper Airway

  2018cites this paper
• OSA Endotypes: What Are They and What Are Their Potential Clinical Implications?

  2018cites this paper
• Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals

  2018cites this paper
• Respiratory Pathologies Associated with Obesity

  2018cites this paper
• From CPAP to tailored therapy for obstructive sleep Apnoea

  2018cites this paper
• Assessing ventilatory instability using the response to spontaneous sighs during sleep in preterm infants

  2018cites this paper
• Neural memory of the genioglossus muscle during sleep is stage‐dependent in healthy subjects and obstructive sleep apnoea patients

  2018cites this paper
• Breath‐holding as a means to estimate the loop gain contribution to obstructive sleep apnoea

  2018cites this paper
• Challenges and perspectives in obstructive sleep apnoea

  2018cites this paper
• Prolonged partial obstruction during sleep is a NREM phenomenon.

  2018cites this paper
• Phenotyping Pharyngeal Pathophysiology using Polysomnography in Patients with Obstructive Sleep Apnea

  2018cites this paper
• Narrative review of contemporary treatment options in the care of patients with obstructive sleep apnoea

  2017cites this paper
• Personalized Management Approach for OSA

  2017cites this paper
• Which place of pharmacological approaches beyond continuous positive airway pressure to treat vascular disease related to obstructive sleep apnea?☆

  2017cites this paper
• Personalized Management Approach for Obstructive Sleep Apnea

  2017cites this paper
• Obstructive sleep apnoea of mild severity: should it be treated?

  2017cites this paper
• Effect of 4‐Aminopyridine on Genioglossus Muscle Activity during Sleep in Healthy Adults

  2017cites this paper
• INVITED REVIEW SERIES: RESPIRATORY SLEEP DISORDERS

  2017cites this paper
• Stable Breathing in Patients With Obstructive Sleep Apnea Is Associated With Increased Effort but Not Lowered Metabolic Rate

  2017cites this paper
• Is the Muscle the Only Potential Target of Desipramine in Obstructive Sleep Apnea Syndrome?

  2017cites this paper
• Reply: Is the Muscle the Only Potential Target of Desipramine in Obstructive Sleep Apnea Syndrome?

  2017cites this paper